Dexcom | DXCM - 营业利润



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 34.01B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


营业利润 更改 日
Abbott USD 2.13B 281M 2026-06
Align Technology USD 191.32M 13.27M 2026-06
AtriCure USD 9.66M 9.14M 2026-06
Baxter International USD 276M 210M 2026-06
Becton, Dickinson and Co. USD 752M 125M 2026-06
Boston Scientific USD 1.24B 190M 2026-06
Cooper Companies USD 222M 253M 2026-06
Dexcom USD 318.3M 63M 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Globus Medical USD -45.97M 209.97M 2026-06
Inogen USD -7.79M 728K 2024-09
Insulet USD 129.7M 7.7M 2026-06
Integra LifeSciences USD 41.29M 29.82M 2026-06
J&J USD 7.48B 860M 2026-06
Medtronic USD 1.84B 254M 2026-06
Merit Medical Systems USD 60.4M 16.25M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Solventum Corp USD 181M 96M 2026-06
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD -13.79M 3.64M 2026-06
Teleflex USD 73.07M 36.04M 2026-06
West Pharmaceutical Services USD 179.1M 2M 2026-06
Zimmer Biomet Holdings USD 344.7M 50.4M 2026-06